Biao He
Venture Partner @ Foothill Ventures
Palo Alto, United States
Biao He is a seed investor at Foothill Ventures in Palo Alto focused on Biotechnology and Genetics. Biao serves as an Investment Partner at TEEC Angel Fund. He is a medical diagnostic expert with the research direction mainly on new methods of gene detection and treatments of human cancers.Biao is co-founder and CTO of Beijing ACCB Biotech Ltd since 2004. The company is committed to the implementation of modern molecular biology technologyresearch and the development of new cancer detection technologies and methods. It also pioneered and promoted the concept of “personalized cancer treatment” in China.In addition, Biao is currently an associate professor of Surgery and Cancer Research Center at University of California, San Francisco (UCSF).Biao holds his Ph.D. in Molecular Genetics from University of Virginia and his bachelor and master degrees in Biology from Tsinghua University, Beijing.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Biao He invests in
Stages Biao He invests in
Countries Biao He invests in
Investment Focus
Industry
- Biotechnology 2 (67%)
- Genetics 1 (33%)
- Manufacturing 1 (33%)
- Semiconductor 1 (33%)
- Bioinformatics 1 (33%)
Stage
- Seed 1 (33%)
- Series A 1 (33%)
- Funding Round 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Cardea Bio
|
Cardea is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors. Cardean transistors leverage biocompatible graphene instead of silicon and replace optical signal observations with direct electrical molecular signal analysis. With Cardean transistors, the company and its Innovation Partners cangenerate streaming multi-omics data to measure real-time biological signals. Cardea is now manufacturing chips at scale and partners have started to significantly expand the amount, type, and quality of biological data they capture by building products that Conduct Biolog. | $7.5M / Series A / Sep 17, 2020 | |
Cureseq
|
CureSeq’s mission is to revolutionize next-generation sequencing in the oncology space by making it more affordable, offering faster time to results with a comprehensive solution. They offer products to advance your research endeavors, and will open their services shortly. Turnaround time using their products is 48 hours from extraction throughgenerating clinically relevant mutations. CureSeq’s technology is born out of the Applied Genomics Thoracic Oncology Lab of Dr. Il-Jin Kim at UCSF. | Aug 12, 2016 | |
|
Cureseq
|
CureSeq’s mission is to revolutionize next-generation sequencing in the oncology space by making it more affordable, offering faster time to results with a comprehensive solution. They offer products to advance your research endeavors, and will open their services shortly. Turnaround time using their products is 48 hours from extraction throughgenerating clinically relevant mutations. CureSeq’s technology is born out of the Applied Genomics Thoracic Oncology Lab of Dr. Il-Jin Kim at UCSF. | Seed / Jul 10, 2014 |
Co-Investors
About Foothill Ventures
Foothill Ventures is a technology-focused venture fund that invests in seed-to-A-round startups in the United States. It is a successor fund to the TEEC Angel Fund. Foothill Ventures was founded in 2017 and is headquartered in Los Altos, California.
Foothill Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Biao He
Venture Partner
|
|||
Eric Rosenblum
Managing Partner
|
|||
Hong Ge
Venture Partner
|
|||
|
Jiazi Guo
Investment Manager
|
|||
Jinlin Wang
Managing Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Biao He invest in?
Biao He invests primarily in Biotechnology, Genetics and Manufacturing startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Biao He last invest?
The most recent investment recorded for Biao He closed in Sep 2020. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
